www.standoutstocks.com: Stocks That Stand Out For Nov. 19th, 2009 Are MTVO, NYMH, ACTC, VSYM, CSUH

Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com _________________________________________________

Montavo Announces Engineering Development for the iPhone and iPod Touch to Coincide With the Release of Rev. 3.0

BELLEVUE, WASHINGTON, Nov 19, 2009 -- Montavo, Inc. (OTCBB: MTVO | Quote | Chart | News | PowerRating) is pleased to announce that the Company has prioritized engineering development efforts for mDealFinder(TM), the company's flagship mobile application, as well as the Montavo Mobile Advertising Platform (mMAP) for the Apple iPhone and Apple iPod Touch so the platform will be supported with the release of Rev. 3.0 planned for Q1 2010.

With over 100 million iPhone and iPod Touch downloaded applications each month via the App Store, the Apple platform has clearly set the standard for mobile applications.

Montavo recently announced an initiative to upgrade the overall user interface (UI) and user experience (UX) of both the mDealFinder(TM) application as well as mMAP suite of online tools for advertisers. These enhancements will also be incorporated into the iPhone and iPod Touch mDealFinder(TM) application which are focused on providing seamless, intuitive user interactions.

"We're very excited about our recent focus and prioritization of the development for the iPhone and iPod Touch mDealFinder(TM) application," said Brook Lang, CEO of Montavo. "With the rapidly growing footprint of both devices, we're looking forward to providing consumers with an innovative, intuitive, free application that will help them save significant dollars on everything from groceries to dress shoes to flat screen TVs in real-world store locations. Our ability to deliver mobile coupons, product information & launches, discounts, and savings opportunities to consumers by marrying their location with retailers that are offering the best deals on products or services they are looking to buy is unparalleled." About Montavo, Inc.

Montavo, Inc.'s mMAP is a mobile marketing platform that integrates client side mobile device software with a mobile advertising network solution and ad distribution ecosystem. Montavo offers its solution to consumer focused advertisers (manufacturers and retailers from national brands to SMBs), wireless carriers, mobile handset manufacturers and mobile OS providers, personal navigation device (PND) manufacturers, automotive manufacturers, and other tier-one suppliers as either a white-labeled mobile application or as the Montavo branded mDealFinder(TM).

Montavo's proprietary, patent-pending mobile advertising platform has been designed from the ground up to deliver the most relevant, location-based deals on products or services to consumers while providing rich real-time data and analytics on mobile ad campaign performance and ROI to advertisers that primarily sell their products in a brick and mortar setting.

Forward Looking Statements: This press release may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations reflected in such forward-looking statements will prove to have been correct. Montavo's actual results could differ materially from those anticipated in the forward-looking statements. Montavo refers you to the cautionary statements and risk factors set forth in the documents it files with the Securities and Exchange Commission (http://www.sec.gov). The Company is under no obligation (and expressly disclaims any obligation) to update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.

NYMET Holdings Inc. (NYMH) Announces Commencement of Ferry Barge Project Salvage and Recycling

NEW YORK, NY, Nov 18, 2009 -- NYMET Holdings Inc. (PINKSHEETS: NYMH), an innovative metals and mining company, headquartered in Port Jefferson, N.Y., today announced the commencement of salvage operations for the M/V San Leandro and the M/V Fresno on the San Joaquin River.

With concentrated efforts by its contractors, Enterprise Marine Co. and B'NEATH THE WAVES, all required equipment has been mobilized at NYMET's port facility and the heavy-duty crane barges have dispatched the ferries to begin the recycling and recovery process. Enterprise Marine spokesperson and owner Loren Beldso stated, "The mobilization of all our equipment is now complete and we are ahead of schedule, however there is still a significant amount of work and salvage to be done in Delta." This Project marks the first of many salvage operations that will utilize NYMET's port facility. NYMET has begun to research additional vessels that need salvaging in the area. NYMET believes that this facility will provide long-term sustainability and substantial revenues for the Company. Further, the facility will also be used to load and transport scrap metal to NYMET clients both domestically and overseas.

About the Stockton, CA Port Facility The facility is located on the waterfront of the San Joaquin River in Stockton, CA. This location provides NYMET with the ability to process scrap metal material from ferry barges and other vessels. Further, the facility also acts as a staging and loading area, giving NYMET the ability to transport material to the Oakland Port as well as local steel mills.

The Stockton Port is one of the last waterfront properties in California that is allowed to operate as a storage and marine salvage facility. The property's proximity to the Oakland Port enables NYMET to cost effectively export material to Asia. The facility's riparian rights permit NYMET to have barges docked and stored at the facility.

DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS The results described herein cannot be guaranteed. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions. These expectations and assumptions are subject to risks and uncertainty, which could affect NYMET Holdings Inc.'s future. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of NYMET Holdings Inc. to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, and other risks. NYMET Holdings Inc. undertakes no duty to update any forward-looking statement(s) and/or to conform the statement(s) to actual results or changes in NYMET Holdings Inc.'s expectations.

Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells to Treat Eye Disease

WORCESTER, Mass., Nov 19, 2009 -- Advanced Cell Technology, Inc. (OTCBB:ACTC) announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina. As many as 10 million people in the United States have photoreceptor degenerative disease. While most of these patients have Age-Related Macular Degeneration (AMD), a smaller number of patients have Stargardt's, an Orphan disease and one of the most common forms of juvenile macular blindness. The treatment for eye disease uses stem cells to re-create a type of cell in the retina that supports the photoreceptors needed for vision. These cells, called retinal pigment epithelium (RPE), are often the first to die off in SMD and AMD, which in turn leads to loss of vision.

While there is currently no treatment for SMD, several years ago ACT and its collaborators found that human embryonic stem cells could be a source of RPE cells. Subsequent studies found that the cells could restore vision in animal models of macular degeneration. In the Royal College of Surgeon (RCS) rat model, implantation of RPE cells resulted in 100% improvement in visual performance over untreated controls without any adverse effects. The cells survived for more than 220 days and sustained extensive photoreceptor rescue. Functional rescue was also achieved in the 'Stargardt's' mouse with near-normal functional measurements recorded at more than 70 days.

"It has been over a decade since human embryonic stem cells were first discovered," said Dr. Robert Lanza, ACT's Chief Scientific Officer. "The field desperately needs a big clinical success. After years of research and political debate, we're finally on the verge of showing the potential clinical value of embryonic stem cell research. Our research clearly shows that stem cell-derived retinal cells can rescue visual function in animals that otherwise would have gone blind. We are hopeful that the cells will be similarly efficacious in patients." The Phase I/II trial will be a prospective, open-label study that is designed to determine the safety and tolerability of the RPE cells following sub-retinal transplantation to advanced patients with SMD. A total of twelve patients will be enrolled into the study at three clinical sites, including the Casey Eye Institute in Portland, Oregon (headed by Dr. Peter Francis of the Oregon Health & Sciences University); the University of Massachusetts Memorial Medical Center, Worcester, Massachusetts (headed by Dr. Shalesh Kaushal, Chair of the Department of Ophthalmology); and the UMDNJ -- New Jersey Medical School, Newark, New Jersey (headed by Dr. Marco Zarbin, Chair, Institute of Ophthalmology and Visual Science). "It is an honor for us to be working with ophthalmology researchers of such high caliber," said Edmund V. Mickunas, Advanced Cell's Vice President of Regulatory Affairs. "They have been instrumental as collaborators on the clinical trial design and their input has been invaluable." "The filing of this IND places Advanced Cell Technology in position to help lead the industry in validating the stem cell platform," said William M. Caldwell IV, Advanced Cell's Chairman and CEO. "Over the past year, we have taken important steps to advance our RPE program while overcoming significant financial challenges. Advanced Cell today is uniquely positioned within the regenerative medicine industry; as it has the technology, a renown scientific and development team and access to capital to become one of the first companies to make the use of an embryonic stem cell derived therapy a reality in treating a major unmet medical need." About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.

Forward-Looking Statements Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

View Systems Announces Substantial ViewScan Order From the UAE

Baltimore, MD, Nov 19, 2009 -- View Systems, Inc. (OTCBB:VSYM), a security and teledata solutions provider, announced today that an initial order for 40 ViewScan units has been received from Belcom, a Belhasa company, based in the United Arab Emirates. Belcom is an authorized international dealer and business partner of View Systems. Belcom represents View Systems' products in the Middle East, Africa, Saudi Arabia, Kuwait, Qatar, Bahrain, UAE, Oman, Jordan, Iraq, India, Pakistan, Bangladesh and Yemen. Belcom is a subsidiary of the Belhasa Group of Companies, a trusted security and services firm with proven performance throughout the Middle East and North Africa. Belcom is one of the fastest growing telecommunications, IT, and security services companies in the Middle East today. Belcom's corporate headquarters is based in Dubai, UAE with field offices located throughout the MENA region. The Belcom team has an impressive track record of successfully completing projects for clients regardless of location. (Source: www.belcom.ae). ViewScan units are currently placed in Saudi Arabia, Bahrain, UAE, India and Pakistan.

View is currently procuring the parts necessary to complete a build of more than 100 units. The 40 units purchased under this contract are expected to ship by the 2009 year end.

ViewScan is fast becoming the choice screening system, both domestically and internationally. It's a computer-based system that can scan up to 1200 people per hour. As a person passes through the portal, a photograph is taken and stored on the laptop computer that comes with the unit. Threat objects are visually located on the computer screen and an audible alert can be set to sound. The ViewScan produces no harmful emissions so it's safe for everyone.

Gunther Than, CEO of View Systems, states, "We have always maintained great enthusiasm for international product sales. Substantial orders from our international dealers are a testament to the reliability and value of the ViewScan product. Belcom has proven itself as a strong representative by successfully marketing our products to their target areas and bringing in orders. We are confident that international interest will steadily rise, and that Belcom will continue to increase our sales abroad." About View Systems: View Systems, Inc. manufactures and installs weapons detection identification systems, video management platforms and tele-data communication networks targeted towards correctional facilities, schools, courthouses, government agencies, event and sports venues, and commercial businesses. More information can be found on the website at www.viewsystems.com.

Forward-Looking Statements: This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Celsius Holdings Files Registration Statement for the Sale of Common Stock; Board Authorizes 1 for 20 Reverse Stock Split CSUH to Apply for NYSE AMEX Listing

DELRAY BEACH, FL, Nov 19, 2009 -- Celsius Holdings, Inc. (OTCBB: CSUH | Quote | Chart | News | PowerRating) today announced that it has filed a registration statement with the Securities and Exchange Commission relating to a proposed offering of 2,500,000 shares of common stock (after giving effect to a 1 for 20 reverse stock split to be implemented prior to consummation of the offering as described below). The registration statement indicates the common stock will be offered in an underwritten offering at a price per share to be determined, through Ladenburg Thalmann & Co. Inc as lead underwriter. Celsius Holdings, Inc. intends to grant the underwriter a 45-day option to purchase additional shares of common stock to cover over-allotments, if any.

Net proceeds from the proposed offering are expected to be used for 2010 marketing efforts, new product development and general corporate purposes, including working capital.

In connection with the proposed offering, the board of directors authorized a 1 for 20 reverse stock split, in which all our issued and outstanding shares of common stock will be combined and reconstituted as a smaller number of shares of common stock, in a ratio of one share of common stock for every 20 shares of common stock. Our authorized shares of capital stock will be reduced proportionately from 1,000,000,000 to 50,000,000 shares of common stock and from 50,000,000 to 2,500,000 shares of preferred stock. The reverse stock split will be implemented prior to the effective date of the registration statement and we will advise our shareholders of the record and effective dates for the reverse stock split in a subsequent press release. Application will also be made to list our common stock for trading on NYSE Amex upon consummation of the proposed offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification of such securities under the securities laws of any such state. This offering will be made only by means of a prospectus. When available, copies of the prospectus may be obtained from Ladenburg Thalmann & Co. Inc., 4400 Biscayne Blvd., Miami, Florida 33137 or toll free at 866-576-5134.

About Celsius Holdings, Inc.

Celsius Holdings, Inc. (OTCBB: CSUH | Quote | Chart | News | PowerRating) markets Celsius(R), the original, great tasting calorie burner that is backed by science, through its wholly-owned operating subsidiary, Celsius, Inc. Celsius, Inc. is dedicated to providing healthier, everyday refreshment through science and innovation. Information about Celsius Holdings, Inc. is available at our website. More information about Celsius, the original, great tasting calorie burner, is available at http://www.celsius.com.

Forward-Looking Statements This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings' future results of operations and/or financial position, or state other forward-looking information. In some cases you can identify these statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will," "would," or similar words. You should not rely on forward-looking statements since Celsius Holdings' actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include, but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business; and other risks and uncertainties discussed in the reports Celsius Holdings files from time to time with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release.

About Standoutstocks.com www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button.

Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx

CONTACT: Jason A. Hilton, Standout Stocks Tel: +1 585 729 8809 e-mail: Jason@Newmediaadvisorsllc.com e-mail: info@standoutstocks.com WWW: http://www.standoutstocks.com

CONTACT: Jason A Hilton, Standout Stocks
Tel: +1 585 729 8809
e-mail: Jason@Newmediaadvisorsllc.com
e-mail: info@standoutstocks.com
WWW: http://www.standoutstocks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (ACTC) ACTC. (ACTC) has Short Term PowerRatings at TradingMarkets. Details on (ACTC) Short Term PowerRatings is available at This Link.

For full details on (CSUH) CSUH. (CSUH) has Short Term PowerRatings at TradingMarkets. Details on (CSUH) Short Term PowerRatings is available at This Link.

For full details on (CSUHE) CSUHE. (CSUHE) has Short Term PowerRatings at TradingMarkets. Details on (CSUHE) Short Term PowerRatings is available at This Link.

For full details on (VSYM) VSYM. (VSYM) has Short Term PowerRatings at TradingMarkets. Details on (VSYM) Short Term PowerRatings is available at This Link.

For full details on (MTVO) MTVO. (MTVO) has Short Term PowerRatings at TradingMarkets. Details on (MTVO) Short Term PowerRatings is available at This Link.

For full details on (NYMH) NYMH. (NYMH) has Short Term PowerRatings at TradingMarkets. Details on (NYMH) Short Term PowerRatings is available at This Link.